Timothy R Franson - Net Worth and Insider Trading
Timothy R Franson Net Worth
The estimated net worth of Timothy R Franson is at least $167,928 dollars as of 2024-11-13. Timothy R Franson is the Director of Paratek Pharmaceuticals Inc and owns about 72,000 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $160,560. Timothy R Franson is also the Director of Cidara Therapeutics Inc and owns about 550 shares of Cidara Therapeutics Inc (CDTX) stock worth over $7,368. Details can be seen in Timothy R Franson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy R Franson has not made any transactions after 2023-02-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy R Franson
Timothy R Franson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy R Franson owns 3 companies in total, including Cidara Therapeutics Inc (CDTX) , Paratek Pharmaceuticals Inc (PRTK) , and Myrexis Inc (MYRX) .
Click here to see the complete history of Timothy R Franson’s form 4 insider trades.
Insider Ownership Summary of Timothy R Franson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | 2021-09-13 | director |
| PRTK | Paratek Pharmaceuticals Inc | 2023-09-21 | director |
| MYRX | Myrexis Inc | 2011-12-08 | director |
Timothy R Franson Latest Holdings Summary
Timothy R Franson currently owns a total of 2 stocks. Among these stocks, Timothy R Franson owns 72,000 shares of Paratek Pharmaceuticals Inc (PRTK) as of February 21, 2023, with a value of $160,560 and a weighting of 95.61%. Timothy R Franson also owns 550 shares of Cidara Therapeutics Inc (CDTX) as of September 13, 2021, with a value of $7,368 and a weighting of 4.39%.
Latest Holdings of Timothy R Franson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2023-02-21 | 72,000 | 2.23 | 160,560 |
| CDTX | Cidara Therapeutics Inc | 2021-09-13 | 550 | 13.40 | 7,368 |
Holding Weightings of Timothy R Franson
Timothy R Franson Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy R Franson has made a total of 1 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 7,000 shares on February 21, 2023, which brought Timothy R Franson around $13,160.
According to the SEC Form 4 filings, Timothy R Franson has made a total of 1 transactions in Cidara Therapeutics Inc (CDTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cidara Therapeutics Inc is the acquisition of 350 shares on September 13, 2021, which cost Timothy R Franson around $14,840.
Insider Trading History of Timothy R Franson
- 1
Timothy R Franson Trading Performance
GuruFocus tracks the stock performance after each of Timothy R Franson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy R Franson is -12.52%. GuruFocus also compares Timothy R Franson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy R Franson within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy R Franson's insider trading performs compared to the benchmark.
Performance of Timothy R Franson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.94 | | | | | |
| Relative Return to S&P 500(%) | -2.37 | | | | | |
Timothy R Franson Ownership Network
Ownership Network List of Timothy R Franson
Ownership Network Relation of Timothy R Franson
Timothy R Franson Owned Company Details
What does Cidara Therapeutics Inc do?
Who are the key executives at Cidara Therapeutics Inc?
Timothy R Franson is the director of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , Chief Medical Officer Taylor Sandison , and director & President & CEO Jeffrey Stein .
Cidara Therapeutics Inc (CDTX) Insider Trades Summary
Over the past 18 months, Timothy R Franson made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 30,407 shares made by Leslie Tari , a net sale of 40,379 shares made by Taylor Sandison , and a net purchase of 58,000 shares made by Jeffrey Stein .
In summary, during the past 3 months, insiders sold 1,833 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 1,833 shares. During the past 18 months, 7,751 shares of Cidara Therapeutics Inc (CDTX) were sold and 11,000 shares were bought by its insiders, resulting in a net purchase of 3,249 shares.
Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cidara Therapeutics Inc Insider Transactions
Timothy R Franson Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy R Franson. You might contact Timothy R Franson via mailing address: 320 Wakara Way, Salt Lake City Ut 84108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
